Flagship Ventures Opportunities Fund I, L.P. insider trades: Axcella Health (AXLA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Flagship Ventures Opportunities Fund I, L.P. reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 13, 2022 | AXLA | ↑ Buy | 5,501,235 | $1.64 | $9.0M | By Flagship Ventures Fund IV, L.P. | Oct 17, 2022 (4d) |
| Oct 13, 2022 | AXLA | ↑ Buy | 3,048,780 | $1.64 | $5.0M | By FPA, L.P. | Oct 17, 2022 (4d) |
| Oct 13, 2022 | AXLA | ↑ Buy | 1,833,745 | $1.64 | $3.0M | By Flagship Ventures Opportunities I, L. | Oct 17, 2022 (4d) |
| May 27, 2022 | EVLO | ↑ Buy | 13,698,630 | $1.46 | $20.0M | By Flagship Pioneering Fund VII, L.P. | Jun 1, 2022 (5d) |
| May 27, 2022 | EVLO | ↑ Buy | 6,849,315 | $1.46 | $10.0M | By Nutritional Health LTP Fund, L.P. | Jun 1, 2022 (5d) |
| May 27, 2022 | EVLO | ↑ Buy | 4,383,561 | $1.46 | $6.4M | By Flagship Ventures Fund IV, L.P. | Jun 1, 2022 (5d) |
| May 27, 2022 | EVLO | ↑ Buy | 1,369,863 | $1.46 | $2.0M | By Flagship Ventures Opportunities Fund | Jun 1, 2022 (5d) |
| May 27, 2022 | EVLO | ↑ Buy | 1,095,890 | $1.46 | $1.6M | By Flagship Ventures Fund IV-Rx, L.P. | Jun 1, 2022 (5d) |
| Mar 16, 2022 | AXLA | ↑ Buy | 3,791,623 | $1.91 | $7.2M | By Flagship Ventures Fund IV, L.P. | Mar 18, 2022 (2d) |
| Mar 16, 2022 | AXLA | ↑ Buy | 1,579,843 | $1.91 | $3.0M | By Flagship Ventures Opportunities I, L. | Mar 18, 2022 (2d) |
| Mar 16, 2022 | AXLA | ↑ Buy | 947,905 | $1.91 | $1.8M | By Flagship Ventures Fund IV-Rx, L.P. | Mar 18, 2022 (2d) |
| Mar 19, 2021 | RUBY | ↑ Buy | 210,000 | $29.00 | $6.1M | Indirect | Mar 23, 2021 (4d) |
| Feb 8, 2021 | KLDO | ↑ Buy | 215,000 | $11.50 | $2.5M | Indirect | Feb 10, 2021 (2d) |
| Feb 2, 2021 | EVLO | ↑ Buy | 130,000 | $15.00 | $1.9M | Indirect | Feb 4, 2021 (2d) |
| Oct 27, 2020 | FHTX | ↑ Buy | 150,000 | $16.00 | $2.4M | Indirect | Oct 29, 2020 (2d) |
| Jun 29, 2020 | EVLO | ↑ Buy | 4,666,666 | $3.75 | $17.5M | Indirect | Jul 1, 2020 (2d) |
| Jun 4, 2020 | KLDO | ↑ Buy | 2,000,000 | $7.50 | $15.0M | Indirect | Jun 8, 2020 (4d) |
| May 18, 2020 | AXLA | ↑ Buy | 3,800,000 | $4.75 | $18.1M | Indirect | May 20, 2020 (2d) |
| May 13, 2019 | AXLA | ↑ Buy | 500,000 | $20.00 | $10.0M | Indirect | May 15, 2019 (2d) |
| Mar 4, 2019 | KLDO | ↑ Buy | 933,333 | $15.00 | $14.0M | Indirect | Mar 6, 2019 (2d) |
| May 11, 2018 | EVLO | ↑ Buy | 281,250 | $16.00 | $4.5M | Indirect | May 15, 2018 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Flagship Ventures Opportunities Fund I, L.P.'s insider trades
Flagship Ventures Opportunities Fund I, L.P. is a 10% owner of Axcella Health (AXLA). Since May 11, 2018, it has reported 21 open-market purchases worth $161.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (5 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.